Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

This page is alzhub.org's plain-English summary of a published study, not the paper itself. It is generated from the record we hold for this study, sourced and linked below — check the original for the full text and methods.

✓ Peer-reviewed alzhub usefulness score 69 out of 100. Digital health tools

Topic: Risk, prevention and care in population studies

Our prediction model was internally evaluated based on five-fold cross-validation on discrimination and calibration, and it was further compared with existing prediction scales. The model was internally validated in the general population of European ancestry and White ethnicity; thus, further validation with independent datasets is necessary to confirm these findings.

Key findings

Why it matters

This study used machine learning on a large, long-running population sample to build a tool that estimates a person's chance of developing dementia. The authors tested it only inside their own data (five-fold cross-validation, checking both how well it separated people and how accurate its risk estimates were) and compared it with existing risk scales. They say it was validated only in people of European ancestry and White ethnicity and needs testing in independent datasets before the findings can be confirmed; it is a prediction tool, not a treatment or prevention.

Study details

How this study scored 69/100
How this study's score is builtJournal tier 7 of 10; Journal's citation record 2 of 4; Study design 7 of 12; Strength of evidence 3 of 5; Peer-review validation 10 of 10; How recent 3 of 5; Sample size 3 of 4; Effect reported 3 of 3; Studied in people 3 of 3; Randomised / blinded 0 of 2; Times cited 5 of 7; Citations per year 3 of 5; Impact for its field and year 4 of 6; Cited by studies here 3 of 6; Still being cited 3 of 4; Senior author's track record 3 of 4; Institution's track record 1 of 3; Multi-centre collaboration 2 of 3; Indexed in PubMed 2 of 2; Free to read 2 of 2. Total 69 of 100.69 of 100 points earned31 not earned

Published in a peer-reviewed journal, and it is a longitudinal study following the same people over time. Scored zero for randomised / blinded because the record does not state it.

ComponentPointsWhy
Journal tier 7 / 10 Tier 3 — peer-reviewed journal (EClinicalMedicine)
Journal's citation record 2 / 4 EClinicalMedicine: journal h-index 150 (OpenAlex, 2026-10-29)
Study design 7 / 12 A longitudinal study following the same people over time
Strength of evidence 3 / 5 Rated “moderate” in our summary
Peer-review validation 10 / 10 Peer-reviewed. Published as an article in a named peer-reviewed journal.
How recent 3 / 5 2022 — within 6 year(s) of the newest study here
Sample size 3 / 4 2,416 participants
Effect reported 3 / 3 Effect reported with a statistic (interval, p-value, ratio or similar)
Studied in people 3 / 3 Studied in people (participant count stated)
Randomised / blinded 0 / 2 No randomisation or blinding stated — scores zero (not stated in the record — scored 0)
Times cited 5 / 7 Cited 105 times (OpenAlex, 2026-10-10)
Citations per year 3 / 5 17.5 citations a year over 6 year(s) since 2022
Impact for its field and year 4 / 6 Cited 12.2× the average for papers of its field and year (OpenAlex FWCI)
Cited by studies here 3 / 6 Cited by 12 other studies in this library
Still being cited 3 / 4 Cited 84 times in 2024–2026 (2026 still in progress; OpenAlex)
Senior author's track record 3 / 4 Last-listed author Wei Cheng: h-index 53 (OpenAlex, whole career)
Institution's track record 1 / 3 Fudan University: institution h-index 954 (OpenAlex)
Multi-centre collaboration 2 / 3 OpenAlex lists 5 institution(s) in 1 country
Indexed in PubMed 2 / 2 Indexed in PubMed (PMID 36187723)
Free to read 2 / 2 Free to read
Total 69 / 100 —

What each of these 20 components measures, and what this score is not →

Read the original

Full text: free to read — OpenAlex lists this copy as free to read: the link above (checked 6 Feb 1020).

Cite this study APA, Vancouver, BibTeX · download .bib or .ris

Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. The record names 7 authors; APA and Vancouver show the first six, BibTeX and the downloads carry all of them. Check the citation against the original before you use it.

APA 7th

You, J., Zhang, Y. R., Wang, H. F., Yang, M., Feng, J. F., Yu, J. T., et al. (2022). Development of a novel dementia risk prediction model in the general population: A large, longitudinal, population-based machine-learning study. EClinicalMedicine. https://doi.org/10.1016/j.eclinm.2022.101665

Vancouver

You J, Zhang YR, Wang HF, Yang M, Feng JF, Yu JT, et al. Development of a novel dementia risk prediction model in the general population: A large, longitudinal, population-based machine-learning study. EClinicalMedicine. 2022. doi:10.1016/j.eclinm.2022.101665. PMID: 36187723.

BibTeX

@article{you2022-36187723,
  author  = {You, J. and Zhang, Y. R. and Wang, H. F. and Yang, M. and Feng, J. F. and Yu, J. T. and Cheng, W.},
  title   = {{Development of a novel dementia risk prediction model in the general population: A large, longitudinal, population-based machine-learning study}},
  journal = {EClinicalMedicine},
  year    = {2022},
  doi     = {10.1016/j.eclinm.2022.101665},
  pmid    = {36187723},
  url     = {https://doi.org/10.1016/j.eclinm.2022.101665}
}

Studies this one cites

Referenced by this study and also in the alzhub library, so you can read them here.

Later studies that cite this one

12 studies in the alzhub library list this one in their references. Showing the 8 highest-scoring.

Related studies in Digital health tools

Also tagged “prevalence”

1,224 studies in the library carry the topic tag “prevalence”; these are this study's neighbours in a fixed, alphabetical-by-hash tour of them, not the closest in content. All 1,224 tagged studies.

Similar studies

More on Digital health tools

See all studies in Digital health tools →